Hughes N C, Phillips D H
Haddow Laboratories, Institute of Cancer Research, Sutton, Surrey, UK.
Carcinogenesis. 1993 Jan;14(1):127-33. doi: 10.1093/carcin/14.1.127.
Benzo[ghi]perylene (B[ghi]P) is a polycyclic aromatic hydrocarbon (PAH), present in complex combustion products, and evidence for its carcinogenic activity in experimental animals is equivocal, and yet it has demonstrable mutagenic activity in vitro. In order to investigate the possible DNA binding properties of B[ghi]P, groups of male Parkes mice were treated topically with 1.0 mumol of B[ghi]P. Mice were killed up to 3 months after treatment, DNA was isolated from the treated areas of skin and analysed for adducts by 32P-postlabelling. Maximum levels of binding (0.57 fmol/microgram DNA) were detected 2 days after treatment and adducts were found to persist for at least 12 weeks after treatment, a property of many PAHs with known tumor-initiating activity. B[ghi]P also became bound to DNA in vitro in the presence of 3-methylcholanthrene-induced rat liver microsomal preparations. When chromatographed on PEI-cellulose, the major adducts formed by B[ghi]P in vivo and in vitro appeared to be identical. However, they were found to be different when compared by reversed-phase HPLC. These differences might explain, in part, the differences in the biological activity of B[ghi]P in vivo and in vitro. The behaviour of B[ghi]P when present in a mixture was also examined. B[ghi]P was applied topically to mouse skin with six other PAHs at a dose level of 0.25 mumol/PAH/mouse. DNA isolated 24 h after treatment was analysed for adducts by 32P-postlabelling. Whilst the total level of binding was 30% lower than expected from the sum of the binding levels that resulted when the hydrocarbons were applied singly, the formation of B[ghi]P-DNA adducts did not appear to be inhibited. The results have demonstrated that B[ghi]P has significant DNA binding ability in vivo and in vitro and on the basis of its DNA binding ability in mouse skin it would be predicted to be at least a weak tumour initiator. The formation of DNA adducts by B[ghi]P when present in an artificial mixture of PAHs suggest that B[ghi]P may contribute to the DNA binding activity of more complex carcinogenic mixtures.
苯并[ghi]芘(B[ghi]P)是一种多环芳烃(PAH),存在于复杂的燃烧产物中。其在实验动物中的致癌活性证据并不明确,但在体外具有明显的诱变活性。为了研究B[ghi]P可能的DNA结合特性,将雄性帕克斯小鼠分组,局部涂抹1.0微摩尔的B[ghi]P。在处理后长达3个月内处死小鼠,从处理过的皮肤区域分离DNA,并通过32P后标记法分析加合物。处理后2天检测到最大结合水平(0.57飞摩尔/微克DNA),且加合物在处理后至少持续12周,这是许多具有已知肿瘤启动活性的多环芳烃的特性。在存在3-甲基胆蒽诱导的大鼠肝微粒体制剂的情况下,B[ghi]P在体外也能与DNA结合。当在PEI-纤维素上进行色谱分析时,B[ghi]P在体内和体外形成的主要加合物似乎相同。然而,通过反相高效液相色谱比较时发现它们有所不同。这些差异可能部分解释了B[ghi]P在体内和体外生物活性的差异。还研究了B[ghi]P存在于混合物中的行为。将B[ghi]P与其他六种多环芳烃以0.25微摩尔/多环芳烃/小鼠的剂量水平局部涂抹于小鼠皮肤。处理后24小时分离的DNA通过32P后标记法分析加合物。虽然总结合水平比单独应用这些碳氢化合物时的结合水平总和预期低30%,但B[ghi]P-DNA加合物的形成似乎并未受到抑制。结果表明,B[ghi]P在体内和体外均具有显著的DNA结合能力,基于其在小鼠皮肤中的DNA结合能力,预计它至少是一种弱肿瘤启动剂。当B[ghi]P存在于多环芳烃的人工混合物中时形成DNA加合物,这表明B[ghi]P可能对更复杂致癌混合物的DNA结合活性有贡献。